$CLVS News Article - Clovis Oncology's Rubraca (rucaparib) Significantly Improves Progression-Free Survival versus Chemotherapy in Patients with Later-line Ovarian Cancer Associated with a BRCA Mutation
https://marketwirenews.com/news-releases/clov...51787.html